Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A successful Series A
July/August 2020
SHARING OPTIONS:

SAN FRANCISCO—Unlearn.AI closed a $12-million Series A financing round led by 8VC, the company announced recently. All existing investors participated as well, including DCVC, DCVC Bio and Mubadala Capital Ventures. In conjunction with this financing, 8VC Principal Dr. Francisco Gimenez joined Unlearn.AI's board of directors. Unlearn.AI intends to use the funds to accelerate the application of its Digital Twins technology in clinical trials. Digital Twin records offer a way to generate control patient data. The records are longitudinal, featuring demographic information, common lab tests, endpoints and/or biomarkers that look identical to official patient records in a trial.
 
“Unlearn's pioneering use of Digital Twins will limit the number of patients that need to go on placebo while also reducing overall trial enrollment time,” remarked Gimenez.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.